GLP Watchdog

Direct Meds vs Hers

Direct Meds has an open FDA warning letter dated September 9, 2025. Hers has an open FDA warning letter dated September 9, 2025. On compounded semaglutide injection, Hers costs $1,176 less a year at standing rates: $199 a month against $297 a month at Direct Meds.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Direct Meds / Hers

Featured pick (affiliate partner)

Direct Meds logo

Direct Meds

7.1/10

Hers logo

Hers

6.8/10

FDA warning letters
Pharmacy
None named in our record
Lowest standing price
$249/moCompounded oral semaglutide
$199/moCompounded semaglutide injection
States
48 states and DC
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026
Visit Direct Meds
Visit Hers

Direct Meds is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Hers pays us nothing. The scores are computed the same way for both and are shown as computed (Direct Meds 7.1, Hers 6.8). How we are paid

What the record shows

  1. 01

    Direct Meds has an open FDA warning letter dated September 9, 2025. Hers has an open FDA warning letter dated September 9, 2025.

  2. 02

    Hers names three pharmacies. Direct Meds names no compounding pharmacy in our record.

  3. 03

    On compounded semaglutide injection, Hers costs $1,176 less a year at standing rates: $199 a month against $297 a month at Direct Meds.

  4. 04

    Only Direct Meds lists a price for compounded tirzepatide injection, compounded oral semaglutide and compounded oral tirzepatide. Only Hers lists a price for brand-name tirzepatide pen.

  5. 05

    Hers covers two states Direct Meds does not.

  6. 06

    Direct Meds holds you to a 90-day supply shipped at once, remaining months billed every 30 days; Hers states you can cancel at any time.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Direct Meds

Hers

Compounded semaglutide injection

$297/mo

$3,564 a year

$199/moLower

$2,388 a year

Compounded tirzepatide injection

$399/mo

$4,788 a year

Not sold or not priced
Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Compounded oral semaglutide

$249/mo

$2,988 a year

Not sold or not priced
Compounded oral tirzepatide

$299/mo

$3,588 a year

Not sold or not priced
Price includes
Medication, clinician visits, shipping
Medication
Billed separately
Not stated
Clinician visits, coaching
Cancel any time
No
Yes, stated
Minimum term
90-day supply shipped at once, remaining months billed every 30 days
None
Refunds
No refunds for medication already received; $35 disposal fee on returns
No refund guaranteed once the pharmacy has processed an order

Read off each seller’s own pages. Direct Meds: October 17, 2026. Hers: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Direct Meds

7.1/10
Featured pick (affiliate partner)
  • Sells compounded tirzepatide injection and compounded oral semaglutide, which Hers does not price
  • Price includes clinician visits
  • Open FDA warning letter, September 9, 2025
  • Names no compounding pharmacy
  • Minimum commitment before you can cancel
Visit Direct Meds

The case for Hers

6.8/10
  • $1,176 a year less on compounded semaglutide injection
  • Sells brand-name tirzepatide pen, which Direct Meds does not price
  • Names its compounding pharmacy
  • States you can cancel at any time
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
Visit Hers

Scores

Direct Meds 7.1 · Hers 6.8 out of 10. Six weighted parts.

Value25%

4.2A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

4.5A
vs
B
7.0

Accessibility10%

9.7A
vs
B
10.0

Support10%

7.0A
vs
B
3.0

The score is the same formula for every seller. Payment does not enter it. Method

Direct Meds vs Hers: questions

Direct Meds has an open FDA warning letter dated September 9, 2025. Hers has an open FDA warning letter dated September 9, 2025. Letters are matched to a seller by company, domain and address, never by a similar name.
Hers names three pharmacies. Direct Meds names no compounding pharmacy in our record.
Hers, by $1,176 a year at standing rates. Direct Meds: $297 a month, about $3,564 a year. Hers: $199 a month, about $2,388 a year.
Direct Meds has a minimum term (90-day supply shipped at once, remaining months billed every 30 days). Hers states you can cancel at any time; refunds: no refund guaranteed once the pharmacy has processed an order.
Direct Meds is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Hers pays us nothing. The scores are computed the same way for both and are shown as computed (Direct Meds 7.1, Hers 6.8).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks